Individual Study / Portland Kaiser Cohort Study

Portland Kaiser Cohort Study

Portland Kaiser Cohort Study

Initiatives -
Start Year
1989
Funding
Intramural Research Program of the National Institutes of Health,National Cancer Institute

Members

Download
Investigators Contacts
  • Dr. Mark Schiffman
    National Cancer Institute

Design

Study design
Population cohort
Follow Up
Annual cytologic screening of women at Kaiser continued as part of standard clinical practice(the women were followed prospectively by routine cytology for a maximum of 18 years follow up)

Marker Paper

Schiffman, M., Glass, A. G., Wentzensen, N., Rush, B. B., Castle, P. E., Scott, D. R., Buckland, J., Sherman, M. E., Rydzak, G., Kirk, P., Lorincz, A. T., Wacholder, S., & Burk, R. D. (2011). A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 20(7), 1398–1409. https://doi.org/10.1158/1055-9965.EPI-11-0206

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
19,921
Number of participants with biosamples
Supplementary Information
Non-pregnant women aged 16 and older

Access

Availability of data and biosamples

Data
Biosamples
Other